By: Miles S.B. No. 2455
A BILL TO BE ENTITLED
AN ACT
relating to the medical use of low-THC cannabis by patients with
certain medical conditions.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 169.003, Occupations Code, is amended to
read as follows:
Sec. 169.003. PRESCRIPTION OF LOW-THC CANNABIS. A
physician described by Section 169.002 may prescribe low-THC
cannabis to a patient if:
(1) the patient is a permanent resident of the state;
(2) the physician complies with the registration
requirements of Section 169.004; and
(3) the physician certifies to the department that:
(A) the patient is diagnosed with:
(i) epilepsy;
(ii) a seizure disorder;
(iii) multiple sclerosis;
(iv) spasticity;
(v) amyotrophic lateral sclerosis;
(vi) autism;
(vii) cancer;
(viii) an incurable neurodegenerative
disease;
(ix) post-traumatic stress disorder; or
(x) Glaucoma;
(xi) Human Immunodeficiency Virus;
(xii) Acquired Immune Deficiency Syndrome;
(xiii) Sickle Cell Disease;
(xiv) Alzheimer's Disease; or
(x)(xv) a medical condition that is approved
for a research program under Subchapter F, Chapter 487, Health and
Safety Code, and for which the patient is receiving treatment under
that program; and
(B) the physician determines the risk of the
medical use of low-THC cannabis by the patient is reasonable in
light of the potential benefit for the patient.
SECTION 2. This Act takes effect September 1, 2023.